HOME >> MEDICINE >> NEWS
Popular anti-epileptic drug also effective in controlling debilitating symptom of multiple sclerosis

A study published in the December issue of Archives of Neurology and currently available online shows that levetiracetam reduced phasic spasticity, which is marked by spasms and painful muscle cramps, in 100 percent of patients in a small clinical study.

"It's amazing how many MS patients can't walk, can't move, and you treat their spasticity and they're fine," said Dr. Kathleen Hawker, assistant professor of neurology at UT Southwestern and lead author of the study. "What's nice about these drugs is that they also work for nerve pain, which in turn improves the patient's mood, so we can use one drug for three things instead of prescribing pain killers and antidepressants in addition to the spasticity therapies."

Spasticity is often seen in patients with MS and amyotrophic lateral sclerosis (ALS), as well as after a stroke or spinal-cord injury. It can lead to loss of balance, increased risk of falls, pain, fatigue, and walking difficulties.

Drugs currently used to treat spasticity may cause memory problems, weakness and lethargy in some patients.

"We're trying to look at medicines that can be used for multiple symptoms so we don't get into a lot of drug interactions," Dr. Hawker said. "If we can get the same results with a better-tolerated drug, that's great for our patients."

Researchers examined the histories of 11 patients treated with levetiracetam between January 2001 and June 2002 for MS-related spasticity at Southwestern Medical Center. The patients were treated with levetiracetam for one to four months, with dosages starting at 250 milligrams per day and increasing to 3,000 mg per day. Researchers found that leviteracetam decreased phasic spasticity in patients taking the drug alone as well as in those who took it in combination with other therapies for spasticity. Tonic spasticity, which produces stiffness, did not improve. Overall, the clinical investigators found the side effects of levetiracetam to be gener
'"/>

Contact: Rachel Horton
rachel.horton@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
15-Dec-2003


Page: 1 2

Related medicine news :

1. Popular chewing gum eliminates bacteria that cause bad breath
2. Popular drug for chest pain may promote blood vessel damage
3. Popular long-acting contraceptive linked to vascular dysfunction
4. Popular asthma drug inadequate when used alone, new study shows
5. Popular herbal remedy fails effectiveness test for tinnitus
6. Popular notions about breast cancer-psychology link challenged
7. Sexually Oriented Internet Sites Are Popular And Non-Problematic For Most People, But Pose Risks For Some
8. UCSF Study Finds Popular Blood Thinner Does Not Weaken Bones
9. Survey Finds Increasing Popularity Of Acute Stroke Teams In U.S. Hospitals
10. Strategy effective against drug resistant tuberculosis
11. Study shows patch therapy may be as effective as oral medications

Post Your Comments:
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Curly Hair ... 14, the largest beauty event in the US, featuring products from all over the ... Keeper™ Collection. The Collection is a line of hair styling products focused entirely on ...
(Date:6/29/2015)... Petersburg, FL (PRWEB) , ... June 30, 2015 , ... ... a special 50% Off offer. The oil, ideal for natural skincare and even ... natural and easy way is something most people desire, and Oil Pulling can accomplish ...
(Date:6/29/2015)... ... June 30, 2015 , ... The United States Equestrian Federation (USEF) ... it becomes the Official Physical and Occupational Therapists of the U.S. Eventing Team. ... Event presented by Land Rover. , “The USEF is pleased to welcome the ...
(Date:6/29/2015)... ... June 30, 2015 , ... The ... for Neuro Musculoskeletal Thermography and Sympathetic Skin Response Studies.* , The new peer-reviewed ... published in 2006, are intended to aid physicians and thermal technologists in the ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... to educate readers and potential patients about a variety of plastic surgery and ... dentistry and more. , It has been the main focus of Cosmetic Town ...
Breaking Medicine News(10 mins):Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:KORT Physical Therapy Announces Partnership with The United States Equestrian Federation 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 3Health News:Board of Advisors Now Coming to Cosmetic Town 2
(Date:6/29/2015)... , June 30, 2015 , ... Corning and Gerresheimer enter into a 10-year-supply ... amount to EUR 196m debt-free Corning and ... for the pharmaceutical glass packaging market Gerresheimer,s outlook ... reflect the future disposal of the tubing business , ...
(Date:6/29/2015)... 29, 2015 EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... underwritten public offering of units. Each unit will consist ... to purchase common stock and Series B warrants to ... the offering would result in them beneficially owning more ...
(Date:6/29/2015)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced ... 1000 Index, effective June 26, 2015. The Russell 1000 ... the U.S. equity universe. It is a subset of ... the largest securities based on a combination of their ... are pleased to be added to this important index, ...
Breaking Medicine Technology:Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3
Cached News: